Boulder-based pharmaceuticals manufacturer N30 Pharma reported Monday that it has appointed Dr. Joseph Loscalzo to its board of directors. In addition to this role, the firm noted, Loscalzo will chair its Scientific Advisory Board. N30 Pharma said Loscalzo currently serves as Harvard University's Hersey Professor of the Theory and Practice of Medicine and is also physician-in-chief at Brigham and Women's Hospital and editor-in-chief of Circulation. Recently, N30 Pharma added, Loscalzo joined the Board of Harrison's Principles of Internal Medicine. N30 develops small molecule drugs for the treatment of cystic fibrosis.